Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
Yescarta (axicabtagene ciloleucel) - Gilead
Anti-CD19 CAR-T - University of Utah
https://distribution.us.m-anage.com/from.storage?image=iI8mZKVyQCOb0f6sZEQvoiGH51KNXAeD7fHQKQutNqpBwOF7GagTLoDPe1Whddjb0
 
Megan Melody, MD, MS 1; Adit Dharia, MD 2; Megan M. Herr, PhD 3; Nicole Altomare, MD 4; Natalie Grover, MD 5; Colin J Thomas, MD 6; Omar Elghawy, MD 6; Yun Kyoung Tiger, MD 7; Alexandra Noveihed, MD 8; Ari Pelcovits, MD 9; Thomas Ollila, MD 9; Matthew J. Cortese, MD, MPH 3; James Davis, PharmD, BCOP 10; Adam Kidwell, MD 11; Tamara K. Moyo, MD 12; Lindsey Fitzgerald, MD 13; Jonathon B. Cohen, MD, MS 14; Nikesh Shah, MD 1; Alan Kerr, MD, PhD 1; Vaishalee P. Kenkre, MD 15; Geoffrey Shouse, DO, PhD 16; Daniel Antonio, MPH 17; Deborah M. Stephens, DO 5; Nirav N. Shah, MD 18; Jonathan Moreira, MD 17; Shuo Ma, MD, PhD 17; Jane Winter, MD 17; Leo I. Gordon, MD 17; Narendranath Epperla, MD, MS 19,20; Brian T. Hess, MD 21; Reem Karmali, MD, MS 17,22
 
Jan 8, 2026
 
Next